Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
To find out if giving blinatumomab as injections under the skin and olverembatinib can help to control the disease in patients with Ph-positive ALL.
Phase II Clinical TrialBlinatumomabOlverembatinib+2 more
M.D. Anderson Cancer CenterNCT07178912
Phase 2
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
To find out if giving blinatumomab as injections under the skin can help to control MRD and keep the disease from coming back in participants with B-cell ALL.
Phase 2 StudyBlinatumomabAcute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterNCT07192237
Phase 1
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
To learn about the safety and effects of revumenib in combination with blinatumomab in patients with newly diagnosed or relapsed/refractory Ph-negative ALL wit…
BlinatumomabRevumenibLymphoblastic Leukemia+1 more
M.D. Anderson Cancer CenterNCT07283640